Clobazam as An Add on Therapy in Patients with Complex.
- Author:
Yong Tae KWAK
1
;
Jong Sam BAIK
;
Joon Hong LEE
;
Tae Young CHO
;
Soo Chul PARK
;
Byung In LEE
Author Information
1. Department of Patholoogy, Severance-Hospital, Yonsei University, Korea.
- Publication Type:Original Article
- MeSH:
Benzodiazepines;
Humans;
Seizures
- From:Journal of the Korean Neurological Association
1995;13(4):865-871
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
Clobazam is one of the benzodiazepine compounds consisting of different structure compared to previously marketed other benzodiazepines. In rescent days, the antiepileptic effects of this drug has been recognized and used in epileptic patients. To confirm the efficacy and side effects of clobazam, we review the records of the 60 patients who was medicated clobazam more than 9 months. These patients had complex partial seizure with unsatisfactory control despite of adequate drug dosage and duration. Among these patients, the improved one were 23 (38. 3%), and tolerant one were 25 with 5.6 month mean remission duration. Only the 7 of 60 patients complained the adverse symptoms and this were not serious enough to discontinue medication. In conclusion, clobazam is relatively safe and efficacious medication enough to try for patients with unsatisfactory seizure control.
